Novel Peptides Derived from Frog Toxin Show Promise for RNA Targeting

RNA-binding peptides are emerging as powerful tools in biotechnology and medicine, offering a versatile platform for modulating gene expression, delivering therapeutic cargo, or inhibiting viral replication. Odorranalectin, a lectin isolated from the skin of the frog Odorrana grahami, is known for its diverse biological activities, but its potential for specific RNA interaction has been largely unexplored. This study specifically addresses the knowledge gap in designing and optimizing Odorranalectin-derived peptides for targeted RNA binding applications, moving beyond broad binding capabilities to engineer precise and high-affinity RNA recognition.